Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03865654 · ClinicalTrials.gov registry record · NA
Individualizing Surveillance Mammography for Older Breast Cancer Survivors
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT03865654 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 45 participants.
The verdict
NCT03865654, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This research is being conducted to develop consensus on surveillance mammography and follow-up for breast cancer survivors who are age ≥75.
Interventions
- OTHER Communication Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2019-05-16 |
| Est. Completion | 2021-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03865654
The ClinicalTrials.gov registry entry for NCT03865654 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Communication Tool is the first listed.
NCT03865654 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03865654 about?
NCT03865654 is a clinical study titled "Individualizing Surveillance Mammography for Older Breast Cancer Survivors". This research is being conducted to develop consensus on surveillance mammography and follow-up for breast cancer survivors who are age ≥75.
What is the current status of trial NCT03865654?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2019-05-16. Estimated completion is 2021-07-01.
What interventions are being tested in trial NCT03865654?
The interventions under investigation include: Communication Tool (OTHER).
Who is sponsoring clinical trial NCT03865654?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.